Akèy › Sindrom liberasyon sitokin › Kalifòni
Etid klinik pou Sindrom liberasyon sitokin nan Kalifòni
3 etid pou Sindrom liberasyon sitokin ap chèche patisipan nan sit nan Kalifòni.
Tèks ofisyèl etid la (Anglè)
Adult Outpatient Linvoseltamab With Tocilizumab Prophylaxis to Mitigate the Risk of Cytokine Release Syndrome (CRS)
- Berenson Cancer Center, Los Angeles
Ap rekriteFaz 4
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07609940Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
- Community Cancer Institute (CCI), Clovis
- Providence Medical Foundation, Fullerton
- Los Angeles Cancer Network, Glendale
- ak 4 plis
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 11, 2026 · NCT06806033Study of CTO1681 for the Prevention and Treatment of CRS in Patients Receiving CAR T-Cell Therapy
- University of California, Irvine - Chao Family Comprehensive Cancer Center, Orange
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Aug 31, 2026 · NCT05905328Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.